SCHEMBL30453713

SCHEMBL30453713

CC(Oc1nc(-c2ccc(NC(=O)N3CCN(C)CC3)cc2)cnc1N)c1c(Cl)ccc(F)c1Cl

nearest known ligand 0.61

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MET P08581 17/20 0.61
MAP4K2 Q12851 1/20 0.55
MAP3K1 Q13233 1/20 0.55
AAK1 Q2M2I8 1/20 0.55
Q6ZSR9 Q6ZSR9 1/20 0.55
MAP4K5 Q9Y4K4 1/20 0.55
MAP4K3 Q8IVH8 1/20 0.52
ALK Q9UM73 4/20 0.48
AXL P30530 1/20 0.45
ABL1 P00519 1/20 0.44
MST1R Q04912 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488848 1.00 MET (0.61) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL488801 0.95 MET (0.55) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL30453393 0.95 MET (0.55) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL30454392 0.88 MET (0.64) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL489251 0.88 MET (0.64) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL10216416 0.88 MAP4K3 (0.54) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL30452942 0.88 MAP4K3 (0.54) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL488390 0.88 MAP4K3 (0.54) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL488584 0.86 MET (0.58) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL30453896 0.86 MET (0.58) METMAP4K2MAP3K1AAK1Q6ZSR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4599890-A2 SUNITINIB FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2025-08-13 EP disclosed
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed